P42 Budget Impact Analysis of Eculizumab Biosimilar for Treatment of Paroxysmal Nocturnal Hemoglobinuria from Public Hospital Perspective in 2023
| Autor: | Robin, P., De Coucy, A., Hadjadj, C., Moreau F, Petiteau. |
|---|---|
| Zdroj: | In Value in Health June 2024 27(6) Supplement:S10-S10 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect